XML 15 R5.htm IDEA: XBRL DOCUMENT v3.22.1
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
Treasury Stock [Member]
Noncontrolling Interest [Member]
Retained Earnings [Member]
Total
Beginning balance, value at Dec. 31, 2020 $ 26,835 $ 106,501,396 $ (2,157,226) $ (90,014,500) $ 14,356,505
Beginning balance, shares at Dec. 31, 2020 26,834,709          
Stock-based compensation 326,164 326,164
Restricted common stock grant $ 450 (450)
Restricted common stock grant, shares 450,000          
Restricted common stock forfeitures $ (8) 8
Restricted common stock forfeitures, shares (7,500)          
Issuance of common stock through registered direct offering at $3.095 per share and accompanying warrants (net of offering expenses and placement agent discount) $ 2,800 6,726,200 6,729,000
Issuance of common stock through registered direct offering at $3.095 per share and accompanying warrants (net of offering expenses and placement agent discount), shares 2,800,000          
Issuance of common stock through registered direct offering at $2.80 per share and accompanying warrants (net of offering expenses and placement agent discount) $ 3,250 6,614,350 6,617,600
Issuance of common stock through registered direct offering at $2.80 per share and accompanying warrants (net of offering expenses and placement agent discount), shares 3,250,000          
Exercise of pre-funded common stock purchase warrants at $3.095 per share $ 7,200 22,276,800 22,284,000
Exercise of pre-funded common stock purchase warrants at $3.095 per share, shares 7,200,000          
Exercise of pre-funded common stock purchase warrants at $2.80 per share $ 11,050 30,928,950 30,940,000
Exercise of pre-funded common stock purchase warrants at $2.80 per share, shares 11,050,000          
Issuance of pre-funded common stock purchase warrants in connection with the registered direct offerings (1,817,548) (1,817,548)
Issuance of common stock purchase warrants at exercise price of $3.25 per share in connection with the registered direct offerings (49,398,510) (49,398,510)
Net loss 21,721,858 21,721,858
Ending balance, value at Mar. 31, 2021 $ 51,577 122,157,360 (2,157,226) (68,292,642) 51,759,069
Ending balance, shares at Mar. 31, 2021 51,577,209          
Beginning balance, value at Dec. 31, 2021 $ 50,904 124,426,379 56,453 (68,670,497) 55,863,239
Beginning balance, shares at Dec. 31, 2021 50,904,391          
Stock-based compensation 394,749 394,749
Restricted common stock grant $ 715 (715)
Restricted common stock grant, shares 715,000          
Restricted common stock forfeitures $ (15) 15
Restricted common stock forfeitures, shares (15,000)          
Net loss (98,094) (6,600,148) (6,698,242)
Repurchase and cancellation of common stock $ (1,876) (2,061,892) (2,063,768)
Repurchase and cancellation of common stock, shares (1,876,034)          
Distribution to noncontrolling interest in consolidated subsidiary (15,692) (15,692)
Ending balance, value at Mar. 31, 2022 $ 49,728 $ 124,820,428 $ (57,333) $ (77,332,537) $ 47,480,286
Ending balance, shares at Mar. 31, 2022 49,728,357